Acute Kidney Injury Risk and Contrast Volume in Intact Versus Ruptured Endovascular Aneurysm Repair in the Vascular Quality Initiative.


Journal

Vascular and endovascular surgery
ISSN: 1938-9116
Titre abrégé: Vasc Endovascular Surg
Pays: United States
ID NLM: 101136421

Informations de publication

Date de publication:
Aug 2022
Historique:
pubmed: 3 5 2022
medline: 2 7 2022
entrez: 2 5 2022
Statut: ppublish

Résumé

Renal impairment after repair of ruptured abdominal aortic aneurysm has been associated with post-operative mortality. Acute kidney injury (AKI) risk specifically related to contrast administration in endovascular aneurysm repair (EVAR) for intact vs ruptured aneurysms has not been previously described. It was our objective to evaluate the risk of AKI and the association with contrast administration in EVAR for ruptured (rEVAR) and intact (iEVAR) aneurysm repair in the Vascular Quality Initiative (VQI). Adult patients less than 90 years old undergoing EVAR in the VQI without prior abdominal aortic surgery or who were not actively on dialysis preoperatively were included. Patients immediately converted to an open repair were excluded. Patients were grouped by repair urgency, and patient and operative characteristics and outcomes compared. Univariable and multivariable analyses were performed to identify factors associated with the primary outcome of AKI. Survival was evaluated by Kaplan-Meier analysis. Of 38,775 EVAR patients identified, 86.5% underwent elective surgery for an intact aneurysm, 8.4% had urgent surgery for a symptomatic, intact aneurysm, and 5.1% had emergent repair for a ruptured aneurysm. Significant risk factors for AKI included contrast volume, a preoperative eGFR <30 mL/min, procedure urgency, COPD, congestive heart failure (CHF), and total procedure time. The factor most associated with AKI was aneurysm rupture prior to repair (OR 8.6, CI 7.2-10.3, Of all factors assessed, aneurysm rupture was the most and contrast volume the least associated with AKI after EVAR. Further studies should evaluate methods of preventing post-EVAR AKI.

Identifiants

pubmed: 35491983
doi: 10.1177/15385744221098820
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

581-589

Auteurs

Samantha LaFontaine (S)

Department of Cardiothoracic and Vascular Surgery, 2006Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.

Pavel Goriacko (P)

Department of Pharmacy, 2013Montefiore Medical Center, Bronx, NY, USA.

Matthew Carnevale (M)

Department of Cardiothoracic and Vascular Surgery, 2006Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.

Harshal Shukla (H)

Department of Pharmacy, 2013Montefiore Medical Center, Bronx, NY, USA.

John Phair (J)

Division of Vascular Surgery, Department of Surgery, 5944The Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Jeffrey Indes (J)

Department of Cardiothoracic and Vascular Surgery, 2006Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.

Evan Lipsitz (E)

Department of Cardiothoracic and Vascular Surgery, 2006Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.

Issam Koleilat (I)

Department of Surgery, Community Medical Center, 4598RWJ/Barnabas Health, Tom's River, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH